This inventor holds 3 USPTO granted patents. Top assignee: Ciba-Geigy Corporation. Active years: 1976-1986.
Company Filing History:
Years Active: 1976-1986
Title: Innovations of Julius Schmidlin in Steroid Chemistry
Introduction
Julius Schmidlin is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of steroid chemistry, particularly in the development of novel compounds with anti-inflammatory properties. With a total of 3 patents, Schmidlin's work has implications for both pharmaceutical applications and the broader field of medicinal chemistry.
Latest Patents
Schmidlin's latest patents include innovative carboxylic acid esters and derivatives of the androstane series. One of his notable inventions describes novel 17.beta.-methoxycarbonyl derivatives that exhibit high local anti-inflammatory activity without systemic side effects. These compounds are synthesized using conventional steroid chemistry processes. Another patent outlines a new method for manufacturing steroid carboxylic acids and their esters, focusing on the oxidative degradation of specific ketoaldehydes. This process allows for the production of 17- and 17a-carboxylic acids with various functional groups, enhancing the versatility of the resulting compounds.
Career Highlights
Julius Schmidlin has been associated with Ciba-Geigy Corporation, a prominent player in the pharmaceutical and chemical industries. His work at the company has allowed him to explore and develop innovative solutions in steroid chemistry. Schmidlin's research has contributed to advancements in the understanding and application of steroid derivatives in medical treatments.
Collaborations
Schmidlin has collaborated with Michel Biollaz, a fellow researcher in the field. Their partnership has likely fostered the exchange of ideas and expertise, further enhancing the quality and impact of their research.
Conclusion
Julius Schmidlin's contributions to steroid chemistry through his innovative patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence the development of new therapeutic compounds.